Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-10 Sale | 2025-12-12 7:11 pm | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 22,968 | $16 | $367,488 | 46,722 (Direct) | View |
| 2025-03-12 Sale | 2025-03-12 7:48 pm | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 53,000 | $7.59 | $402,270 | 69,690 (Direct) | View |
| 2025-02-04 Sale | 2025-02-12 4:05 pm | HilleVax Inc. | HLVX | HERSHBERG ROBERT See Remarks | 26,535 | $1.8338 | $48,661 | 1,101,498 (Direct) | View |
| 2024-02-08 Sale | 2024-02-12 7:47 pm | HilleVax Inc. | HLVX | HERSHBERG ROBERT See Remarks | 11,597 | $14.93 | $173,161 | 1,354,918 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:45 pm | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 672 | $22.75 | $15,288 | 2,009 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-04 Option Award | 2026-03-06 7:49 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 15,625 | $0 | 62,347 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-06 8:54 pm | N/A 2030-07-05 | Atai Beckley N.V. | ATAI | HERSHBERG ROBERT Director | 719,121 | $0 | 719,121 (Direct) | View |
| 2025-09-17 Equity Swap | 2025-09-17 4:30 pm | N/A N/A | HilleVax Inc. | HLVX | HERSHBERG ROBERT President and CEO | 1,101,498 | $0 | 0 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 5:23 pm | N/A 2035-06-18 | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 66,047 | $0 | 117,763 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 7:15 pm | N/A 2035-03-04 | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 39,120 | $0 | 146,416 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 6:12 pm | N/A 2034-06-03 | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 39,290 | $0 | 77,909 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 7:45 pm | N/A 2034-03-04 | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 79,372 | $0 | 155,340 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 7:47 pm | N/A 2034-02-07 | HilleVax Inc. | HLVX | HERSHBERG ROBERT See Remarks | 401,087 | $0 | 1,354,918 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:20 pm | 2024-06-16 2033-06-16 | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 37,836 | $0 | 637,633 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:09 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:06 pm | N/A 2033-03-06 | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 38,104 | $0 | 99,297 (Direct) | View |
| 2023-02-02 Exercise | 2023-02-03 5:00 pm | N/A 2023-02-04 | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 53,000 | $0 | 61,193 (Direct) | View |
| 2023-02-02 Exercise | 2023-02-03 5:00 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 53,000 | $0.45 | 61,193 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:17 pm | N/A 2033-01-31 | HilleVax Inc. | HLVX | HERSHBERG ROBERT President and CEO | 569,916 | $0 | 1,347,378 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:16 pm | 2023-06-14 2032-06-14 | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 54,435 | $0 | 599,797 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:31 pm | N/A 2032-06-09 | Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:41 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 20,543 | $0 | 22,552 (Direct) | View |
Ownership | 2022-04-28 9:30 pm | N/A N/A | HilleVax Inc. | HLVX | HERSHBERG ROBERT President and CEO | 0 | $0 | 777,462 (Direct) | View |
| 2022-04-18 Exercise | 2022-04-18 8:27 pm | N/A N/A | NanoString Technologies Inc | NSTG | HERSHBERG ROBERT Director | 3,306 | $0 | 11,300 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 7:00 pm | N/A 2032-01-26 | Adaptive Biotechnologies Corp | ADPT | HERSHBERG ROBERT Director | 23,411 | $0 | 24,915 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:45 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 693 | $0 | 7,862 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-05 8:31 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 572 | $0 | 7,169 (Direct) | View |
| 2021-06-04 Option Award | 2021-09-21 5:04 pm | N/A 2031-06-03 | Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 5:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director | 347 | $0 | 6,597 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 7:00 pm | N/A N/A | NanoString Technologies Inc | NSTG | HERSHBERG ROBERT Director | 3,890 | $0 | 11,300 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 7:00 pm | N/A N/A | NanoString Technologies Inc | NSTG | HERSHBERG ROBERT Director | 5,520 | $0 | 11,300 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:33 pm | N/A 2031-06-01 | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 7,015 | $0 | 7,015 (Direct) | View |